Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actonel in periodontal health of postmenopausal women
NCT00594334Phase 4Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in periodontal disease, sponsored by University Hospitals Cleveland Medical Center. Planned start Jan 2008; status: withdrawn.
02
Drugs
risedronate
03
Conditions
periodontal disease
Beyond the preview
Go deeper on NCT00594334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594334.